| Name | Title | Contact Details |
|---|
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
McLaren Racing was founded by racing driver Bruce McLaren in 1963. The team entered its first Formula 1 race in 1966. McLaren has since won 21 Formula 1 world championships, 189 Formula 1 Grands Prix, the Indianapolis 500 three times, and the Le Mans 24 Hours at its first attempt. McLaren Racing competes across six racing series. The team competes in the FIA Formula 1 World Championship with McLaren F1 drivers Lando Norris and Oscar Piastri, the NTT INDYCAR SERIES with Arrow McLaren drivers Pato OWard, Alexander Rossi and Nolan Siegel, the ABB FIA Formula E World Championship with NEOM McLaren Formula E Team drivers Sam Bird and Taylor Barnard, the Extreme E Championship with NEOM McLaren Extreme E Team drivers Cristina Gutiérrez and Mattias Ekström, and F1 Academy with ART Grand Prix and Driver Development programme member Bianca Bustamante. The team also competes in the F1 Sim Racing Championship as McLaren Shadow, having won the 2022 Constructors and Drivers Championships. McLaren is a champion for sustainability in the sport and a signatory to the UN Sports for Climate Action Commitment. It is committed to achieving net zero by 2040 and fostering a diverse and inclusive culture in the motorsport industry.
MedChemExpress offers a wide range of high-quality life science biochemicals, including novel bioactive compounds, recombinant proteins, dye reagents, peptides and natural compounds for laboratory and scientific use. We take pride in offering only the highest-grade products. Product identity, quality, purity and activity are assured by our robust quality control programs and procedures. We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.
YA Group is an international professional services organization with over 25 years of experience, specializing in forensic consulting, engineering, and risk mitigation. Headquartered in the United States, the company employs more than 700 professionals and operates globally. It has evolved from its origins as a property damage consulting firm and has expanded through strategic acquisitions and organic growth. The firm offers a range of services, including forensic engineering and architecture, planning and construction advisory, and risk mitigation. Their expertise covers evaluations of existing structures, project controls, and comprehensive risk reduction strategies. YA Group serves a diverse clientele, including federal agencies, municipalities, healthcare systems, and educational institutions, emphasizing strong partnerships and a commitment to integrity and professionalism. The company is affiliated with several industry organizations, enhancing its credibility and expertise in the field.